首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1485251

臨床化學分析儀市場- 副產品（試劑[緩衝液、對照品]、分析儀[台式、落地式]）、測試（基本代謝、肝臟、腎臟、血脂分析）、模式（集中式、分散式）、最終用途- 全球2024 - 2032 年預測

Clinical Chemistry Analyzers Market - By Product (Reagents [Buffer, Control], Analyzers [Benchtop, Floor-standing]), Test (Basic Metabolic, Liver, Renal, Lipid Profile), Modality (Centralized, Decentralized), End-use - Global Forecast 2024 - 2032

出版日期: 2024年03月07日 | 出版商:

Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在慢性病盛行率上升、老年人口增加以及醫療基礎設施投資不斷增加的推動下，全球臨床化學分析儀市場在 2024 年至 2032 年期間將以 4.1% 的複合年成長率成長。

世界衛生組織 (WHO) 最近的一份報告顯示，非傳染性疾病 (NCD) 目前約佔全球每年死亡人數的 75%。隨著糖尿病、心血管疾病和腎臟疾病等疾病在全球範圍內變得越來越普遍，對準確、及時的診斷解決方案的需求越來越大。臨床化學分析儀透過測量患者樣本中的各種生物標記和參數，在診斷和監測這些慢性病方面發揮著至關重要的作用。隨著慢性病負擔持續升級，對臨床化學分析儀的需求可能會增加，從而推動市場成長。此外，檢測技術的進步以及用於檢測和管理慢性病的新型檢測方法的開發進一步促進了市場的擴張。

臨床化學分析儀市場根據產品、測試、模式、最終用途和地區進行分類。

由於集中式分析儀能夠有效處理大量樣本，集中式分析儀細分市場將在預測期內顯著成長。這些分析儀提供自動化測試程序、縮短週轉時間並提高準確性，從而提高實驗室的整體生產力。隨著對集中檢測設施簡化診斷流程和改善患者護理的需求不斷成長，預計該細分市場將進一步成長。

到 2032 年，肝臟檢測領域將累積相當大的臨床化學分析儀市場佔有率，因為肝臟檢測對於評估肝臟的整體健康和功能至關重要。肝臟檢測包括一組生物標記，如丙胺酸轉氨酶(ALT)、天門冬胺酸轉氨酶(AST)、膽紅素和鹼性磷酸酶(ALP) 等，有助於診斷和監測各種肝臟疾病，包括肝炎、肝硬化、及肝癌。隨著飲酒、肥胖和病毒感染等因素的推動，全球肝病盛行率不斷上升，對肝臟檢測的需求顯著增加。

在醫療保健基礎設施快速擴張、醫療保健支出增加以及人們對早期疾病診斷重要性的認知不斷提高的支持下，亞太地區臨床化學分析儀行業預計在 2024 年至 2032 年期間實現大幅成長。中國、印度和日本等國家正在醫療保健技術和基礎設施方面進行大量投資，推動先進診斷解決方案的採用，包括臨床化學分析儀。此外，慢性病的日益普及正在擴大對診斷服務的需求，從而推動不同醫療保健環境的市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 老年人口不斷增加
  - 慢性疾病和生活方式疾病的盛行率不斷增加
  - 擴大採用現場護理測試設備
  - 對實驗室自動化的需求不斷成長
- 產業陷阱與挑戰
  - 儀器成本高
  - 資金投入要求高
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2018 年 - 2032 年

主要趨勢
試劑
- 緩衝器
- 校準器
- 控制
- 標準
- 其他試劑
分析儀
- 依技術
  - 半自動分析儀
  - 全自動分析儀
  - 照護端分析儀
- 按類型
  - 桌上型分析儀
  - 落地式分析儀
其他產品

第 6 章：市場估計與預測：按測試類型，2018 年 - 2032 年

主要趨勢
基礎代謝組
肝臟面板
腎臟概況
脂質譜
甲狀腺功能面板
電解板
特種化學測試

第 7 章：市場估計與預測：按模式，2018 年 - 2032 年

主要趨勢
集中
去中心化

第 8 章：市場估計與預測：按最終用途，2018 - 2032 年

主要趨勢
醫院和診所
專科診所
診斷實驗室
其他最終用戶

第 9 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Abbott Laboratories
Danaher Corporation
EKF Diagnostics
F.Hoffmann-La Roche Ltd.
Hitachi Ltd.
HORIBA Ltd.
Ortho Clinical Diagnostics
QuidelOrtho Corporation
Siemens Healthineers AG
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Sysmex Corporation
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 8435

Global Clinical Chemistry Analyzers Market will grow at 4.1% CAGR during 2024-2032, driven by the rising prevalence of chronic diseases, increasing geriatric population, and growing investments in healthcare infrastructure.

A recent World Health Organization (WHO) report shows that non-communicable diseases (NCDs) now account for approximately 75% of global deaths annually. With conditions such as diabetes, cardiovascular diseases, and kidney disorders becoming more prevalent globally, there is an increasing need for accurate and timely diagnostic solutions. Clinical chemistry analyzers play a crucial role in diagnosing and monitoring these chronic conditions by measuring various biomarkers and parameters in patient samples. As the burden of chronic diseases continues to escalate, the demand for clinical chemistry analyzers could rise, driving market growth. Additionally, advancements in testing technologies and the development of novel assays for detecting and managing chronic diseases further contribute to the market expansion.

The Clinical Chemistry Analyzers Market is classified based on product, test, modality, end-use, and region.

The centralized analyzers segment will register significant growth during the forecast period due to the ability of centralized analyzers to handle a high volume of samples efficiently. These analyzers offer automated testing procedures, reduced turnaround time, and enhanced accuracy, thus improving overall laboratory productivity. With the growing demand for centralized testing facilities to streamline diagnostic processes and improve patient care, further segment growth is expected.

Liver panel segment will amass a decent Clinical Chemistry Analyzers Market Share by 2032 as the liver panel test is vital in assessing the overall health and function of the liver. Comprising a panel of biomarkers such as alanine transaminase (ALT), aspartate transaminase (AST), bilirubin, and alkaline phosphatase (ALP), among others, liver panel tests aid in the diagnosis and monitoring of various hepatic conditions, including hepatitis, cirrhosis, and liver cancer. With the rising prevalence of liver diseases globally, fueled by factors such as alcohol consumption, obesity, and viral infections, the demand for liver panel testing is witnessing a notable upsurge.

Asia Pacific Clinical Chemistry Analyzers industry is poised for substantial growth over 2024-2032, supported by a rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and rising awareness regarding the importance of early disease diagnosis. Countries like China, India, and Japan are making significant investments in healthcare technology and infrastructure, driving the adoption of advanced diagnostic solutions, including clinical chemistry analyzers. Furthermore, the growing prevalence of chronic diseases is amplifying the demand for diagnostic services, thereby propelling market growth across diverse healthcare settings.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising geriatric population
  - 3.2.1.2 Increasing prevalence of chronic disorders and lifestyle diseases
  - 3.2.1.3 Growing adoption of point of care testing devices
  - 3.2.1.4 Increasing demand for laboratory automation
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of instruments
  - 3.2.2.2 Requirement for high capital investment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Reagents
- 5.2.1 Buffers
- 5.2.2 Calibrators
- 5.2.3 Controls
- 5.2.4 Standards
- 5.2.5 Other reagents
5.3 Analyzers
- 5.3.1 By technology
  - 5.3.1.1 Semi-automatic analyzers
  - 5.3.1.2 Fully automatic analyzers
  - 5.3.1.3 Point of care analyzers
- 5.3.2 By type
  - 5.3.2.1 Benchtop analyzers
  - 5.3.2.2 Floor-standing analyzers
5.4 Other products

Chapter 6 Market Estimates and Forecast, By Test Type, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Basic metabolic panel
6.3 Liver panel
6.4 Renal profile
6.5 Lipid profile
6.6 Thyroid function panel
6.7 Electrolyte panel
6.8 Speciality chemical tests

Chapter 7 Market Estimates and Forecast, By Modality, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Centralized
7.3 Decentralized

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinics
8.3 Specialty clinics
8.4 Diagnostic laboratories
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa